🔗 Visit the ClinicalTrials.gov page for NCT00323622
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. | Lancet | 2005 | 4.68 |
| 2 | Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. | J Infect Dis | 2009 | 2.36 |
| 3 | Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. | Vaccine | 2011 | 1.07 |